The Potential Impact of High-Risk Human Papillomavirus-Negative Cervical Intraepithelial Neoplasia 2+ on Primary Human Papillomavirus Screening.
Anna Daniela IacoboneFabio BottariMaria E GuerrieriAilyn M Vidal UrbinatiMariacristina GhioniNoemi SpoltiIda PinoRita PasseriniRaffaela C Di PaceDorella FranchiEleonora P PretiPublished in: American journal of clinical pathology (2021)
Our results showed a not-negligible proportion of high-risk-HPV-negative CIN2+, suggesting that cotesting would not miss these cases.